Bausch Health Companies Inc. (BHC)
NYSE·Healthcare·Drug Manufacturers - Specialty & Generic
$5.89
-2.96%
Mkt Cap $2.45B
Analyst Ratings
No recent rating data.
Price Target (12 analysts)
$9.83
Range $8.00 – $16.00
Implied Upside
+66.9%
Consensus $9.83 vs current $5.89